Vivani Medical, Inc.
$1.51
▲
8%
2026-04-21 10:05:01
www.vivani.com
NCM: VANI
Explore Vivani Medical, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$127.82 M
Current Price
$1.51
52W High / Low
$1.92 / $0.92
Stock P/E
—
Book Value
$0.21
Dividend Yield
—
ROCE
-84.04%
ROE
-1.6%
Face Value
—
EPS
$-0.43
Exp Qtr EPS
—
Sector
Healthcare
Industry
Biotechnology
Employees
42
Beta
3.37
Debt / Equity
119.87
Current Ratio
2.71
Quick Ratio
2.71
Forward P/E
-2.97
Price / Sales
—
Enterprise Value
$90.66 M
EV / EBITDA
-3.34
EV / Revenue
—
Rating
Strong Buy
Target Price
$4.83
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Ocugen, Inc. | $1.85 | — | $606.61 M | — | -307.31% | -7.77% | $2.73 / $0.64 | $-0.04 |
| 2. | AEON Biopharma, Inc. | $1.07 | — | $25.81 M | — | 252.78% | -46.26% | $1.45 / $0.38 | $-4.54 |
| 3. | Context Therapeutics Inc. | $2.26 | — | $223.27 M | — | -65.65% | -46.39% | $3.62 / $0.49 | $0.66 |
| 4. | Caribou Biosciences, Inc. | $2.29 | — | $212.6 M | — | -90.82% | -78.97% | $3.54 / $0.71 | $1.28 |
| 5. | Polyrizon Ltd. | $11.64 | — | $20.34 M | — | -27.56% | -25.38% | $2,235 / $2.88 | $13.05 |
| 6. | Harmony Biosciences Holdings, Inc. | $29.53 | 10.93 | $1.73 B | — | 20.45% | 20.75% | $40.87 / $25.52 | $15.07 |
| 7. | Evogene Ltd. | $0.8 | — | $7.92 M | — | -84.53% | -1.01% | $2.42 / $0.72 | $-0.01 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0 M | 0 M | — |
| Operating Profit | -6.81 M | -6.72 M | -7.46 M | -6.56 M | -6.46 M | — |
| Net Profit | -6.63 M | -6.53 M | -7.14 M | -6.3 M | -6.05 M | — |
| EPS in Rs | -0.08 | -0.08 | -0.08 | -0.07 | -0.07 | -0.11 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0 M |
| Operating Profit | -27.56 M | -24.68 M | -26.96 M | -21.24 M |
| Net Profit | -26.61 M | -23.49 M | -25.65 M | -13.89 M |
| EPS in Rs | -0.31 | -0.28 | -0.3 | -0.16 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 39.39 M | 41.56 M | 45.8 M | 51.13 M |
| Total Liabilities | 23.66 M | 23.95 M | 25.04 M | 6.82 M |
| Equity | 15.73 M | 17.61 M | 20.76 M | 44.31 M |
| Current Assets | 17.9 M | 20.44 M | 23.06 M | 47.53 M |
| Current Liabilities | 6.6 M | 5.99 M | 5.72 M | 6.82 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -24.32 M | -20.79 M | -23.7 M | -18.79 M |
| Investing CF | -1.17 M | -0.56 M | -0.89 M | -0.34 M |
| Financing CF | 23.27 M | 19.05 M | 0.13 M | 63.39 M |
| Free CF | -25.49 M | -21.34 M | -24.59 M | -19.12 M |
| Capex | -1.17 M | -0.56 M | -0.89 M | -0.34 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | — | — | — | — |
| Earnings Growth % | 8.44% | -84.69% | — | — |
| Profit Margin % | — | — | — | — |
| Operating Margin % | — | — | — | — |
| Gross Margin % | — | — | — | — |
| EBITDA Margin % | — | — | — | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2022-08-19 | 1:0.333333 |